This study asked whether the maternal-fetal interface in mice (and humans) serves as an active site of embryonic hematopoiesis, independent of the yolk sac, examining embryonic days E7.5–E19.5 in mice and 5-week human first-trimester placental tissue before HSC emergence.
A previously unrecognized extraembryonic tissue at the maternal-fetal interface, termed MIXER, harbors both classical CSF1R+ erythro-myeloid progenitors (EMPs) and a distinct CD4+CSF1R− embryonic EMP population (eEMPROR), absent from the yolk sac; MIXER contains significantly more CD115+ progenitors than the yolk sac (P=7.8×10⁻³), and eEMPROR cells contribute to perivascular macrophages persisting to at least postnatal day 14. Early human placental villi at 5 weeks of gestation also harbor CD4+CD235a+ nucleated erythroid cells in CD31-lined structures.
The study is primarily descriptive and anatomical; whether MIXER progenitors arise de novo or partially migrate from the yolk sac cannot be fully excluded. Human data come from only 6 donors using fixed tissue, limiting functional characterization. No single-cell transcriptomic or epigenomic data are provided to resolve MIXER's full cellular architecture or its relationship to later placental hematopoiesis.
MIXER is not yet clinically actionable, but identifying this new hematopoietic niche at the maternal-fetal interface updates fundamental models of blood cell origin and may eventually inform understanding of how disruptions at the implantation site—due to placental pathology or maternal inflammation—could affect lifelong macrophage populations and immune homeostasis.
Explore related topics